Renal aspergillosis after COVID ‐19‐associated pulmonary aspergillosis: A case report
Rattachement africain : ir, in, us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Key Clinical Message Renal aspergillosis is a rare condition and this case the first case of Renal aspergillosis reported after COVID‐19‐associated pulmonary aspergillosis. Renal symptoms should arise clinical suspicion to renal involvement that happened as a result of hematogenous spreading of pulmonary aspergillosis. Abstract Secondary fungal infections are among the most significant complications that can arise after COVID‐19 and have the potential to lead to a high rate of morbidity and mortality. As COVID‐19 primarily involves the airway, the majority of fungal infections reported have been related to the respiratory system. However, renal aspergillosis that we have reported is a rare condition that also can occur. A 67‐year‐old man was referred to our hospital and admitted as a COVID‐19 patient. After the initial recovery, he experienced a recurrence of fever accompanied by a productive cough. The histopathological studies were conducted on the sputum and bronchoalveolar lavage samples, which revealed the presence of Aspergillus flavus. We treated the patient with voriconazole and the patient was discharged after a period of time. However, after approximately 6 months, he returned to the hospital with a fever and abdominal pain. We started a fever workup. Two new hypoechoic abscess‐like masses were spotted in the right kidney in the ultrasonography (U/S) and the direct molecular studies of the biopsy sample obtained under U/S guidance identified Aspergillus flavus. Although renal aspergillosis is a rare condition, it should not be overlooked, especially in patients with severe COVID‐19 and pulmonary aspergillosis, as these conditions can lead to renal aspergillosis, which may present with symptoms such as abdominal pain with fever. Therefore, it is necessary to perform radiological and histopathological studies when renal aspergillosis is suspected.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.
- Titre Crossref
- Renal aspergillosis after <scp>COVID</scp>‐19‐associated pulmonary aspergillosis: A case report
- Date Crossref
- 01/09/2023
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Mazandaran University of Medical Sciences Department of Infectious Disease Antimicrobial Resistance Research Center pays non établi dans la noticeUniversité ou école supérieure
-
Tehran University of Medical Sciences pays non établi dans la noticeUniversité ou école supérieure
-
Shiraz University of Medical Sciences Shiraz Neuroscience Research Center pays non établi dans la noticeUniversité ou école supérieure
-
Education and Research Network pays non établi dans la noticeInstitution
-
Universal Scientific Education and Research Network pays non établi dans la noticeOrganisation à but non lucratif
-
American Association of Kidney Patients pays non établi dans la noticeOrganisation à but non lucratif
-
School of Medicine Department of Pathology pays non établi dans la noticeUniversité ou école supérieure
-
Network of Immunity in Infection pays non établi dans la noticeInstitution
Department of Infectious Disease Antimicrobial Resistance Research Center — Mazandaran University of Medical Sciences, Tehran University of Medical Sciences et Shiraz Neuroscience Research Center — Shiraz University of Medical Sciences, avec 5 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.